NZ's Fisher & Paykel Healthcare slips, Morningstar says co overvalued
02/06/2026 01:20
BUZZ-NZ's Fisher & Paykel Healthcare slips, Morningstar says co overvalued Updates
** Shares of Fisher & Paykel Healthcare FPH.NZ fall as much as 1.1% to NZ$36.9, their lowest level since May 26
** Morningstar raises its fair value estimate for FPH to NZ$30.5, reflecting adjustments for the time value of money
** Investment research firm says shares are overvalued, with the market appearing 'too optimistic' about the pace of revenue growth
** Trims its FY2027 payout ratio forecast to 65% from 75%, implying a 12% reduction in dividend to NZ$0.59
** However, Morningstar will revert to a 75% payout ratio assumption upon completion of its fifth facility at the East Tāmaki campus and final land payment at its Karaka site
** YTD, stock down ~2%
(Reporting by Anjali Singh in Bengaluru)
Recent news on Morningstar
See all newsAustralia's Magellan Financial hits 1-1/2-year low; Morningstar cuts fair value estimate on weaker outlook
Street View: Philip Morris to weather cost hit as smoke-free revenue growth in focus
Pressure on lower-income US households raises delinquency risks, Morningstar DBRS says
UK gilt investors expect budget to pass without market drama, Morningstar says
UK gilt investors expect budget to pass without market drama, Morningstar says